3Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopy study with analysis of risk factors. Hepatology, 1990,12:1106-1110. 被引量：1
4Marchesini G, Brizi M, Morselli-Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med,1999, 107:450-455. 被引量：1
6Ueno T, Sugawara H, Sujaku K, et al. Therapeutic effects of restrivted diet and exercise in obese patients with fatty liver. J Hepatol,1997, 27: 103-107. 被引量：1
7Saknena S, Johnson J, Olliff SP, et al. Diet & Exercise: important first steps in the therapy of NASH. Hepatology, 1999, 30:436A. 被引量：1
8Andersen T, Gluud C, Franzmann MB, et al. Hepatic effects of dietary weight loss in morbidly obese subiects. J Hepatol, 1991, 12 :224-229. 被引量：1
9Kawasaki T, Hashimoto N. The relationship between fatty liver and hyperinsulinemia in obese japanese children. J Pediatr Gatroenterol Nutr, 1997, 24:317-321. 被引量：1
10Franzese A, Vajro P, Argenziano A, et al. Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an italian population. Dig Dis Sci, 1997, 42 : 1428-1432. 被引量：1
6Anderson T, Gluud C, Franzmann MB, et al. Hepatic effects of dietary weight loss in morbidly obese subjects. J Hepatol, 1991, 12: 224-227. 被引量：1
7Capron JP, Delamarre J, Dupus JL, et al. Fasting in obesity, another cause of liver injury with alcoholic hyalin? Dig Dis Sci, 1982, 27: 265-268. 被引量：1
8Laurin J, Lindor KD, Crippin JS, et al. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study. Hepatology, 1996, 23: 1464-1467. 被引量：1
